• UMHS
• |
• Psych.Portal
• |
• Events
• |
• Directions and Map

 

In the News

Jon-Kar Zubieta, M.D., Ph.D., was awarded $1.2 million for a project that examines neurobiological mechanisms involved in the development of placebo effects in patients with depression and nicotine dependence. These studies are expected to clarify the predictability of placebo effects and define the neural systems mediating them.
Read more

James Cranford Wins MICHR Award Funding

Jim Abelson Wins Teaching Award from the Association for Academic Psychiatry

Michelle Riba Recognized as one of America’s Top Doctors

Maria Muzik Receives MICHR Funding Award

Divy Ravindranath Recipient of 2010 Laughlin Fellowship Award

Fred Blow Receives 2009 Medical School Dean’s Awards for Faculty

The University of Michigan loses internationally renowned biological psychiatrist to leukemia

U-M Psychiatry Newsroom

 

The U-M Department of Psychiatry

is part of the University of Michigan Health System, one of the nation's leading health care facilities, and is home to the nation's first comprehensive Depression Center and the Molecular and Behavioral Neurosciences Institute.

We provide patients with state-of-the-art treatment and care of psychiatric disorders, much of it based on the innovative research done by our faculty. Our psychiatric care facility is one of the best in the country, and was one of the very first to provide modern diagnosis and research on mental disorders.

On this site you will find information about our physicians and caregivers, clinical specialities and programs, research programs, and educational opportunities.

For Psychiatric Emergency Services, call: (734) 936-5900
To make an appointment, call: (734) 764-0231

Highlights

Maternal depression is associated with significant sleep disturbance Findings suggest that parents, especially ones with a history of depression, should pay close attention to the conditions they create for their infant’s sleep. -read more-

Epilepsy drug may help alcoholics recover from dependence The study, published in the August issue of the journal Alcoholism: Clinical and Experimental Research, suggests that the drug gabapentin might be able to reduce insomnia in recovering alcoholics, and help them stay away from alcohol more successfully. -read more-

 

 

• Addiction Research Center
• |
• U-M Depression Center
• |
• Molecular and Behavioral Neurosciences Institute

• U-M Medical School
• |
• UMHS Home
• |
• U-M Gateway